BCM
EXAS

BlueCrest Capital Management’s Exact Sciences EXAS Stock Holding History

BlueCrest Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-23,700
Closed -$1.64M – 157
2024
Q1 		$1.64M Buy
+23,700
New +$1.5M 0.08% 136
2020
Q1 		– Sell
-11,328
Closed -$1.05M – 279
2019
Q4 		$1.05M Buy
11,328
+8,344
+280% +$734K 0.07% 150
2019
Q3 		$270K Buy
+2,984
New +$340K 0.02% 398
2019
Q2 		– Sell
-33,006
Closed -$2.86M – 629
2019
Q1 		$2.86M Buy
+33,006
New +$2.81M 0.11% 133
2018
Q4 		– Sell
-6,076
Closed -$480K – 1037
2018
Q3 		$480K Sell
6,076
-192,491
-97% -$12.6M 0.01% 777
2018
Q2 		$11.9M Buy
198,567
+188,283
+1,831% +$10.1M 0.31% 55
2018
Q1 		$415K Buy
+10,284
New +$502K 0.01% 873
2016
Q1 		– Sell
-12,865
Closed -$119K – 873
2015
Q4 		$119K Buy
+12,865
New +$120K ﹤0.01% 908

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BlueCrest Capital Management's EXAS Position: Q2 2024 in Review

BlueCrest Capital Management sold out of Exact Sciences (EXAS) in Q2 2024, closing a stake of 23,700 shares — an estimated $1.64M sold.

BlueCrest Capital Management first reported a position in EXAS in Q4 2015 and held it in 8 quarters. The position peaked at $11.9M in Q2 2018. 543 funds tracked by Wall St. Rank hold EXAS as of Q2 2024.

  • BlueCrest Capital Management reported no remaining Exact Sciences position as of Q2 2024 after selling out during the quarter.
  • BlueCrest Capital Management sold 23,700 Exact Sciences shares in Q2 2024, an estimated $1.64M.
  • BlueCrest Capital Management first reported a position in Exact Sciences in Q4 2015 and held it in 8 quarters.
  • BlueCrest Capital Management's Exact Sciences position peaked at $11.9M in Q2 2018.
  • 543 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2024.

Based on BlueCrest Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.